Similar articles for PMID: 16011212

Year	Number of Results
2002	1
2003	3
2004	7
2005	4
2006	3
2007	2
2008	4
2009	7
2010	6
2011	9
2012	6
2013	14
2014	11
2015	8
2016	6
2017	8
2018	4
2019	4
2021	1
2022	1
2024	0

1

Beyond methotrexate: biologic therapy in rheumatoid arthritis.

Ostör AJ. Ostör AJ. Clin Med (Lond). 2005 May-Jun;5(3):222-6. doi: 10.7861/clinmedicine.5-3-222. Clin Med (Lond). 2005. PMID: 16011212 Free PMC article. Review.

2

Biologics in rheumatoid arthritis--recommendations for Swiss practice.

Dudler J, Möller B, Michel BA, Villiger PM. Dudler J, et al. Swiss Med Wkly. 2011 May 10;141:w13189. doi: 10.4414/smw.2011.13189. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21557111 Free article.

3

Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA. Singh JA, et al. Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657. Cochrane Database Syst Rev. 2017. PMID: 28481462 Free PMC article. Review.

4

Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.

Kobayakawa T, Kojima T, Takahashi N, Hayashi M, Yabe Y, Kaneko A, Shioura T, Saito K, Hirano Y, Kanayama Y, Miyake H, Asai N, Funahashi K, Hirabara S, Hanabayashi M, Asai S, Ishiguro N. Kobayakawa T, et al. Mod Rheumatol. 2015 Mar;25(2):251-6. doi: 10.3109/14397595.2014.953668. Epub 2014 Sep 11. Mod Rheumatol. 2015. PMID: 25211402

5

Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.

Kihara M, Davies R, Kearsley-Fleet L, Watson KD, Lunt M, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register. Kihara M, et al. Clin Rheumatol. 2017 Feb;36(2):241-250. doi: 10.1007/s10067-016-3485-5. Epub 2016 Dec 2. Clin Rheumatol. 2017. PMID: 27913894 Free PMC article.

6

Use of abatacept in rheumatoid arthritis.

von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger PM. von Kempis J, et al. Swiss Med Wkly. 2012 May 11;142:w13581. doi: 10.4414/smw.2012.13581. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22581564 Free article. Review.

7

[Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].

Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ. Zoń-Giebel A, et al. Przegl Lek. 2002;59(11):916-8. Przegl Lek. 2002. PMID: 12715722 Review. Polish.

8

Induction therapy with combination TNF inhibitor and methotrexate in early rheumatoid arthritis.

Hwang YG, Moreland LW. Hwang YG, et al. Curr Rheumatol Rep. 2014 May;16(5):417. doi: 10.1007/s11926-014-0417-8. Curr Rheumatol Rep. 2014. PMID: 24619653 Review.

9

Certolizumab pegol: a new biologic targeting rheumatoid arthritis.

Patel AM, Moreland LW. Patel AM, et al. Expert Rev Clin Immunol. 2010 Nov;6(6):855-66. doi: 10.1586/eci.10.69. Expert Rev Clin Immunol. 2010. PMID: 20979550 Free PMC article. Review.

10

Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.

Finckh A, Bansback N, Marra CA, Anis AH, Michaud K, Lubin S, White M, Sizto S, Liang MH. Finckh A, et al. Ann Intern Med. 2009 Nov 3;151(9):612-21. doi: 10.7326/0003-4819-151-9-200911030-00006. Ann Intern Med. 2009. PMID: 19884622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year